Skip to main content
OpenTrials

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,269 public trials 1,194 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Completed

Biomarkers of Response to Pembrolizumab Combined With Chemotherapy in Non-Small Cell Lung Cancer (KEYNOTE-782, MK-3475-782)

NCT03664024

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +13 more
Locations
  • University Of Colorado ( Site 0908) Aurora, Colorado, United States
  • Harry & Jeanette Weinberg Cancer Institute ( Site 0901) Baltimore, Maryland, United States
  • Henry Ford Health System ( Site 0903) Detroit, Michigan, United States
  • Kingston General Hospital ( Site 0800) Kingston, Ontario, Canada
View all 15 locations
View Trial Details
Completed

Local Recurrence Prediction of by Texture Analysis Derived From Positron Emission Tomography (PET / CT) Imaging of Non-small Cell Lung Cancer (NSCLC) Treated With Stereotactic Radiotherapy (SBRT) (Retros MUMOFRAT)

NCT06555861

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • ICO Nantes, Saint Herblain, France
  • CHRU de Brest Brest, France
  • Centre Eugènes Marquis Rennes, France
  • CHU de Tours Tours, France
View Trial Details
Completed

Real-world Data on Stage III NSCLC Patients Treated With Durvalumab After Chemoradiotherapy in Asia Area (PACIFIC AA)

NCT04529564

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • National Taiwan University Hospital-Hsinchu Branch Hsinchu, Taiwan
  • Chang Gung Medical Foundation-Kaohsiung Branch Kaohsiung City, Taiwan
  • Chang Gung Medical Foundation-Keelung Branch Keelung, Taiwan
  • China Medical University Hospital Taichung, Taiwan
View Trial Details
Completed

A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular Alterations

NCT01970865

Conditions
ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations
  • Highlands Oncology Group/Research Fayetteville, Arkansas, United States
  • Highlands Oncology Group Rogers, Arkansas, United States
  • Chao Family Comprehensive Cancer Center Orange, California, United States
  • UC Irvine Medical Center Orange, California, United States
View all 77 locations
View Trial Details

Related conditions